Utility of Choline PET-CT in Prostate Malignancy
This course comprises of a single tutorial where we aim to explore the role of F18 choline imaging in prostate cancer. We aim to explain the background to functional imaging of the prostate and review the evidence for F18 choline in various clinical indications. The intended audience for this course is radiologists and nuclear medicine physicians who intend to train to report on the utility of choline PET-CT in prostate malignancy, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.
It is expected that candidates have prior knowledge of FDG PET-CT imaging before undertaking the tutorials.
Suitable for radiologists and nuclear medicine physicians who intend to train to report on the utility of choline PET-CT in prostate malignancy, or who otherwise encounter these studies in their practice and wish to increase their confidence, for example in the role of a presenting radiologist at an MDT.
Learning Outcomes
-
Sobhan Vinjamuri
Prof. Dr. Sobhan Vinjamuri trained in nuclear medicine in India and the UK at St Bartholomew’s Hospital and Royal Liverpool University Hospital, where he has been a Consultant since 1998 and Lead Consultant since 2005. He chairs the Joint Specialty Committee on Nuclear Medicine at the Royal College of Physicians and is a member of the Administration of Radioactive Substances Advisory Committee. Active in medical ethics, he has chaired Research Ethics Committees since 2004 and serves on the European Association of Nuclear Medicine Ethics Committee.
